Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
20
-
Total shares
-
3.37M
-
Shares change
-
-35.5K
-
Total reported value, excl. options
-
$14.9M
-
Value change
-
-$158K
-
Number of buys
-
10
-
Number of sells
-
-8
-
Price
-
$4.43
Significant Holders of Y-mAbs Therapeutics, Inc. - COM (YMAB) as of Q1 2025
23 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - COM as of Q1 2025.
Y-mAbs Therapeutics, Inc. - COM (YMAB) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.37M shares
.
Largest 10 shareholders include BlackRock, Inc. (2.9M shares), Pictet Asset Management Holding SA (442K shares), RICE HALL JAMES & ASSOCIATES, LLC (104K shares), Bank of New York Mellon Corp (92.5K shares), WESBANCO BANK INC (55K shares), RHUMBLINE ADVISERS (53.9K shares), SAPIENT CAPITAL LLC (43.7K shares), ALPS ADVISORS INC (33.3K shares), EXCHANGE TRADED CONCEPTS, LLC (26.8K shares), and PRINCIPAL FINANCIAL GROUP INC (22.4K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.